Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Dorette van Ingen Schenau

Technician
  • Van Leeuwen group
Dorette van Ingen Schenau

Patient derived xenografts/animal studies
Animal models are still much needed for bringing new therapies to the clinic

Phone -
Email -


My project revolves around establishing and using patient-derived xenografts to study drug responsiveness in acute lymphoblastic leukemia both ex vivo and in vivo.